Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Maquoi, E., Leblond Chain Jeanne, & Piel, G. (29 January 2025). ADVANCING siRNA DELIVERY: DSPE-PNMVA AS A SOLUTION TO THE PEG DILEMMA IN LNP [Paper presentation]. CIRM DAY, Liège, Belgium. |
![]() ![]() | Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Leblond Chain Jeanne, & Piel, G. (03 December 2024). ADVANCING siRNA DELIVERY: DSPE-PNMVA24 AS A SOLUTION TO THE PEG DILEMMA IN LNP FOR TUMOR TARGETING [Poster presentation]. SF Nano. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (07 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (06 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
![]() ![]() | Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Leblond Chain, J., & Piel, G. (28 October 2024). Impact of lipid-polymer type and content on Lipid Nanoparticles (LNPs) physico-chemical properties and protein corona formation [Poster presentation]. CRS BNLF Local Chapter, Gand, Belgium. |
![]() ![]() | Leeten, K., Jacques, N., Esquembre, L. A., Schneider, D. C., Straetener, J., Henriksen, C., MUSUMECI, L., Putters, F., Ferreira Melo, S., Sánchez-López, E., Giera, M., Penoy, N., Piel, G., Verlaine, O., Amoroso, A., Joris, B., Slavetinsky, C. J., Goffin, E., Pirotte, B., ... Oury, C. (2024). Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance. MBio, 0132224. doi:10.1128/mbio.01322-24 ![]() |
Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (12 September 2024). Formulation of a Dry Powder for Inhalation Combining Ciclesonide and Indacaterol [Paper presentation]. Exploring the Future of Inhalation Drug Delivery, Parme, Italy. |
Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (24 April 2024). Poly(N-vinyl amide)-lipid conjugates as poly(ethylene glycol) alternatives for the modification of lipid-based nanocarriers [Paper presentation]. Materials Research Society (MRS) Spring Meeting, Seattle, United States. |
![]() ![]() | Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (17 April 2024). Assessment of the Effects of Drying Methods on Powder Properties: A Comparative Study of Spray Drying from Solution and Suspension [Poster presentation]. 9th Workshop on Pulmonary Drug Delivery, Dublin, Ireland. |
![]() ![]() | Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (10 April 2024). Effect of the composition of liposomes on dexamethasone encapsulation and its kinetics of release [Poster presentation]. ESCDD Symposium 2024, Egmond aan Zee, Netherlands. |
![]() ![]() | Degey, M., Berger, M., Evrard, B., & Piel, G. (10 April 2024). Exploring alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. 17th European Symposium on Controlled Drug Delivery. |
![]() ![]() | Gauthy, C., Evrard, B., Malgrange, B., & Piel, G. (19 March 2024). Optimization of liposomal formulation to achieve sustained release of dexamethasone [Poster presentation]. 14th PBP World Meeting, Vienne, Austria. |
Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (March 2024). Innovative siRNA-based lipid nanoparticles decorated with PEG alternatives (PNVP and PNMVA) to circumvent dilemma and immunogenicity [Paper presentation]. 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, Vienne, Austria. ![]() |
![]() ![]() | Penoy, N.* , Delma, K. L.* , Homkar, N., Karim Sakira, A., Egrek, S., Sacheli, R., Sacre, P.-Y., Grignard, B., Hayette, M.-P., Somé, T. I., Semdé, R., Evrard, B., & Piel, G. (15 February 2024). Development and optimization of a one step process for the production and sterilization of liposomes using supercritical CO2. International Journal of Pharmaceutics, 651, 123769. doi:10.1016/j.ijpharm.2024.123769 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (31 January 2024). Optimization of liposomal composition to efficiently encapsulate dexamethasone or dexamethasone phosphate and enable their sustained release [Poster presentation]. CIRM Day, Liège, Belgium. |
![]() ![]() | Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium. |
Bya, L.-A., Coeurderoi, A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (31 January 2024). STUDY OF THE IMPACT OF DRYING PROCESSES ON POWDER PROPERTIES: A COMPARATIVE ANALYSIS OF SPRAY-DRYING TECHNOLOGY FROM SOLUTION AND SUSPENSION [Paper presentation]. CIRM day 2024 - Scientific Day, Liège, Belgium. |
Piel, G. (17 January 2024). Use of supercritical CO2 for the production and sterilization of liposomes [Paper presentation]. 1st FRITCO2T day, Liège, Belgium. |
Penoy, N., Delma, K. L., Berger, M., Evrard, B., & Piel, G. (2024). Supercritical fluid methods for liposome production and sterilization. In Antimisiaris Sophia G., Liposomes in drug delivery : what, where, how and when to deliver. Elsevier. doi:10.1016/B978-0-443-15491-1.00003-1 ![]() |
![]() ![]() | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Laloy, J., Pendeville-Samain, H., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (02 August 2023). Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery. Journal of Controlled Release, 361, 87 - 101. doi:10.1016/j.jconrel.2023.07.031 ![]() * These authors have contributed equally to this work. |
Piel, G. (10 July 2023). Use of supercritical CO2 for the production and sterilization of liposomes [Paper presentation]. 6th WORKSHOP OF EMJMD NANOMEDICINES FOR DRUG DELIVERY, Patras, Greece. |
![]() ![]() | Tskitishvili, E., Palazzo, C., Foidart, J.-M., Piel, G., & Pequeux, C. (15 June 2023). Use of liposome-encapsulated estetrol for treatment of neonatal hypoxic-ischemic encephalopathy. Brain Research, 1809, 148369. doi:10.1016/j.brainres.2023.148369 ![]() |
![]() ![]() | Gallez, A., Nys, G., Wuidar, V., Dias Da Silva, I., Taziaux, M., Kinet, V., Tskitishvili, E., Noël, A., Foidart, J.-M., Piel, G., Fillet, M., & Pequeux, C. (03 June 2023). Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. International Journal of Molecular Sciences, 24 (11), 9718. doi:10.3390/ijms24119718 ![]() |
![]() ![]() | Penoy, N., Delma, K. L., Grignard, B., Evrard, B., & Piel, G. (23 May 2023). The use of supercritical CO2 to develop liposomes encapsulating active pharmaceutical ingredients for pulmonary administration [Poster presentation]. 19th European Meeting on Supercritical Fluids, Budapest, Hungary. |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (28 April 2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
![]() ![]() | Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (28 April 2023). Development of optimized liposomes for sustained-release transtympanic administration [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Penoy, N., Delma, K. L., EGREK, S., Grignard, B., Sacheli, R., Sacre, P.-Y., Hayette, M.-P., Evrard, B., & Piel, G. (27 April 2023). Supercritical CO2 to produce and sterilize liposomes: How to find supercritical parameters with the QbD strategy [Paper presentation]. BSPS - 21th Forum of Pharmaceutical Sciences, Blankerberge, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. ![]() |
![]() ![]() | Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597 ![]() |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium. |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium. |
![]() ![]() | Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (01 February 2023). Development of a sustained-release form of dexamethasone for the local treatment of sensorineural hearing loss [Poster presentation]. CIRM Day, Liège, Belgium. |
Piel, G. (31 January 2023). Use of supercritical CO2 for the production and sterilization of liposomes in a one-step process [Paper presentation]. Séminaires de la faculté de Pharmacie, Paris, France. |
![]() ![]() | Delma, K. L., Penoy, N., Sakira, A. K., EGREK, S., Sacheli, R., Grignard, B., Hayette, M.-P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (11 January 2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112 - 118. doi:10.1016/j.ejpb.2023.01.002 ![]() |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”. |
Bya, L.-A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (2023). Inhaled dry powder containing lipid-nanoparticles: particle engineering by spray-drying technology [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (15 November 2022). Amphiphilic poly(N-vinylpyrrolidone)-based lipoplex modifiers for drug delivery applications [Paper presentation]. Belgian Polymer Group (BPG) Annual Meeting, Blankenberge, Belgium. |
![]() ![]() | Penoy, N., Delma, K. L., Tonakpon, H. A., Grignard, B., Evrard, B., & Piel, G. (October 2022). An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration. International Journal of Pharmaceutics, 627, 122212. doi:10.1016/j.ijpharm.2022.122212 ![]() |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (14 June 2022). Novel polyvinylpyrrolidone-based lipoplex modifiers for siRNA delivery [Poster presentation]. Bordeaux Polymer Conference, Bordeaux, France. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (01 June 2022). PNVP as PEG alternative for lipoplex modification in siRNA delivery application [Poster presentation]. Advanced Functional Polymers for Medecine (AFPM), Nice, France. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands. |
Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (29 March 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on chemical stability of phospholipids and physicochemical characteristics of a liposome formulation [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Rotterdam, Netherlands. ![]() |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany. |
Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (02 February 2022). Applicability of supercritical carbon dioxide sterilization to liposomes: effects of potential conditions on phospholipids and liposomes stability [Paper presentation]. CIRM day 2022, Liège, Belgium. |
Berger, M., Toussaint, F., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (02 February 2022). PNVP-polymers as a promising polyethyleneglycol (PEG) alternative onto anti-tumor lipoplexes surface [Paper presentation]. CIRM-Day, Liege, Belgium. |
![]() ![]() | Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (January 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on physicochemical characteristics of a liposome formulation containing apigenin. Journal of Supercritical Fluids, 179, 105418. doi:10.1016/j.supflu.2021.105418 ![]() |
Delma, K. L., Evrard, B., Piel, G., Semdé, R., & Sakira, A. K. (04 November 2021). Etude de l’applicabilité de la stérilisation par le dioxyde de carbone supercritique aux liposomes : effets de conditions opératoires sur la stabilité chimique de phospholipides [Paper presentation]. 2ème Congrès de la Société Ouest Africaine de Pharmacie Galénique et Industrielle (SOAPGI), Ouagadougou, Burkina Faso. |
![]() ![]() | Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010 ![]() |
![]() ![]() | Warnon, C., Bouhjar, K., Ninane, N., Verhoyen, M., Fattaccioli, A., Fransolet, M., Lambert de Rouvroit, C., Poumay, Y., Piel, G., Mottet, D., & Debacq-Chainiaux, F. (12 July 2021). HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts. Aging, 13, 17978-18005. doi:10.18632/aging.203304 ![]() |
![]() ![]() | Berger, M., Lechanteur, A., Evrard, B., & Piel, G. (2021). Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120851 ![]() |
Toussaint, F., Berger, M., Sanaa, B. D., Lechanteur, A., Jérôme, C., Piel, G., Mottet, D., & Debuigne, A. (27 May 2021). Polyvinylpyrrolidone compounds as PEG alternatives for lipoplex modification [Poster presentation]. Belgian Polymer Group (BPG) Annual Meeting, remote, Belgium. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Piel, G. (2021). Intéret des liposomes dans le développement des compléments alimentaires. |
![]() ![]() | Penoy, N., Grignard, B., Evrard, B., & Piel, G. (06 April 2021). Double Encapsulation in liposomes for pulmonary administration produced by an innovative supercritical process [Paper presentation]. Controlled Release Society BeNeLux&France Early Career Scientists Meeting (online). ![]() |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (06 April 2021). Amphiphilic N-vinyl pyrrolidone-based polymers as PEG alternatives to avoid blood proteins adsorption around liposomes [Paper presentation]. Early Career Scientist Meeting 2021. |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (04 March 2021). Impact of amphiphilic copolymer used as PEG alternative on the formation of a protein corona around coated-liposomes encapsulating siRNA [Paper presentation]. 2021 - Virtual Local Chapter Meeting Germany and BeNeLux & France, Aachen, Germany. |
Penoy, N., Grignard, B., Evrard, B., & Piel, G. (04 March 2021). A supercritical PGSS method to encapsulate budesonide in liposome: comparison with the classical tFH method [Paper presentation]. CRS Local Chapters Meeting Germany and BeNeLux & France (online). ![]() |
![]() ![]() | Sounouvou, A. G. H. T., Defourny, C., Gbaguidi, F., Ziemons, E., Piel, G., Quetin-Leclercq, J., & Evrard, B. (01 March 2021). Development of a highly persistent silicone-based sprayable emulsion containing essential oils for treatment of skin infections. International Journal of Pharmaceutics, 596. doi:10.1016/j.ijpharm.2021.120214 ![]() |
![]() ![]() | Penoy, N., Koch, N., Grignard, B., Evrard, B., & Piel, G. (March 2021). The quality by design strategy to prepare different liposomes formulations by a new supercritical fluid method [Poster presentation]. APGI Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. ![]() |
![]() ![]() | Bellefroid, C., Reusch, C., Lechanteur, A., Evrard, B., Debacq-Chainiaux, Mottet, D., & Piel, G. (2021). Systematic study of liposomes composition towards efficient delivery of plasmid DNA as potential application of dermal fibroblasts targeting. International Journal of Pharmaceutics, 592, 120122. doi:10.1016/j.ijpharm.2020.120122 ![]() |
![]() ![]() | Delma, K. L., Lechanteur, A., Semde, R., Evrard, B., & Piel, G. (2021). Sterilization methods of liposomes: drawbacks of conventional methods and perspectives. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120271 ![]() |
![]() ![]() | Penoy, N., Grignard, B., Evrard, B., & Piel, G. (2021). A supercritical fluid technology for liposome production and comparison with the film hydration method. International Journal of Pharmaceutics, 592, 120093. doi:10.1016/j.ijpharm.2020.120093 ![]() |
Delma, K. L., Evrard, B., Piel, G., & Semdé, R. (December 2020). Stérilisation des liposomes par le dioxyde de carbone en phase supercritique : effets des conditions sur leurs caractéristiques physicochimiques [Paper presentation]. 1er Journées Scientifiques de l’Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso. |
![]() ![]() | Ledoux, A., Coelho Cristino Mamede, L. C., Palazzo, C., Furst, T., Jansen, O., De Tullio, P., Kagisha, V., Pendeville-Samain, H., Fillet, M., Piel, G., & Frederich, M. (18 May 2020). Heparin-Coated Liposomes Improve Antiplasmodial Activity and Reduce the Toxicity of Poupartone B. Planta Medica International Open, 7 (e), 73–80. doi:10.1055/a-1158-0569 ![]() |
![]() ![]() | Gallez, A.* , Palazzo, C.* , Blacher, S., Tskitishvili, E., Noël, A., Foidart, J.-M., Evrard, B., Pequeux, C.* , & Piel, G.*. (05 January 2020). Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: an innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α. International Journal of Pharmaceutics, 573, 118861. doi:10.1016/j.ijpharm.2019.118861 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Schmitt, C., Lechanteur, A., Cossais, F., Bellefroid, C., Arnold, P., Lucius, R., Held-Feindt, J., Piel, G., & Hattermann, K. (2020). Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices. International Journal of Nanomedicine, 15, 3649—3667. doi:10.2147/IJN.S245300 ![]() |
![]() ![]() | Bellefroid, C., Lechanteur, A., Evrard, B., Mottet, D., Debacq-Chainiaux, F., & Piel, G. (15 December 2019). In vitro skin penetration enchancement techniques: a combined approach of ethosomes and microneedles. International Journal of Pharmaceutics, 572. doi:10.1016/j.ijpharm.2019.118793 ![]() |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Lipid-based nanovectors combined with microneedles to enhance skin penetration of genes: in vitro and in vivo studies [Paper presentation]. 2nd CIRM DAY, Liège, Belgium. |
![]() ![]() | Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium. |
![]() ![]() | Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium. |
![]() ![]() | Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? [Poster presentation]. 2nd CIRM Day. |
![]() ![]() | Ilangala Booka, A., COBRAIVILLE, G., EVRARD, A., Sonveaux, Lechanteur, A., Piel, G., & Fillet, M. (11 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. 2nd Edition of CIRM day, Liege, Belgium. |
![]() ![]() | Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium. |
Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (11 December 2019). Effects of supercritical carbon dioxide sterilization conditions on physicochemical characteristics of liposomes [Poster presentation]. 2nd CIRM day, Liège, Belgium. |
![]() ![]() | Sounouvou, A. G. H. T., Lechanteur, A., Quetin-Leclercq, J., Piel, G., Donneau, A.-F., Gbaguidi, F., & Evrard, B. (2019). Chromametric assessment of drug skin tolerance: A comparative study between Africans and Caucasians skins. Skin Research and Technology. doi:10.1111/srt.12804 ![]() |
Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (27 November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Paper presentation]. 1ER CONGRES DE LA SOCIETE OUEST AFRICAINE DE PHARMACIE GALENIQUE ET INDUSTRIELLE (SOAPGI), Abidjan, Côte d’Ivoire. |
Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Poster presentation]. Journées Scientifiques et portes ouvertes de l'Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (24 September 2019). Nucleic acids skin penetration enhancement: a combined approach of deformable liposomes and microneedles [Paper presentation]. Skin & Formulation 5th Symposium & 17th Skin Forum, Reims, France. |
![]() ![]() | Lechanteur, A., Evrard, B., & Piel, G. (2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.09.001 ![]() |
Sounouvou, A. G. H. T., Defourny, C., Quetin-Leclercq, J., Gbaguidi, F., Piel, G., & Evrard, B. (September 2019). Silicones in development of a highly persistent sprayable emulsion containing essential oils for treatment of common skin infections [Poster presentation]. Skin and Formulation 5th Symposium & 17th Skin Forum, Reims, France. |
![]() ![]() | Penoy, N., Bigazzi, W., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (20 May 2019). LIPOSOME PRODUCTION BY INNOVATIVE METHOD USING SUPERCRITICAL FLUIDS [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., Gbaguidi, F., & Evrard, B. (20 May 2019). Assessment of drug skin tolerance in Africans using a chromameter [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (20 May 2019). Improvement of skin penetration of lipid-based nanocarriers according to their composition [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
![]() ![]() | Ledoux, A., Coelho Cristino Mamede, L. C., Jansen, O., Desdemoustier, P., Palazzo, C., Hamann, C., Piel, G., & Frederich, M. (17 May 2019). Natural compound-containing liposomes: a strategy for targeted activities toward artemisinin-resistant Plasmodium falciparum isolate [Poster presentation]. 4th Phytoday, Belgium. ![]() |
Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., & Evrard, B. (26 March 2019). Assessment of drug skin tolerance in Africans using chromameter [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (25 March 2019). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 3th European Conference on Pharmaceutics, Bologne, Italy. |
Bellefroid, C., Absil, G., Nikkels, A., & Piel, G. (19 February 2019). Innovative therapeutics for actinic keratosis and skin cancer [Paper presentation]. CIRM Seminairs. |
![]() ![]() | Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (2019). Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.02.012 ![]() |
![]() ![]() | Emonts, P., Penoy, N., Rocks, N., Piel, G., Fillet, M., Hubert, P., Ziemons, E., & Evrard, B. (19 January 2019). Update of the progresses and development prospects of the FEDER project Phare [Paper presentation]. CIRM seminars, Liege, Belgium. |
![]() ![]() | Bigazzi, W., Penoy, N., Evrard, B., & Piel, G. (2019). Supercritical fluid methods: an alternative to conventional methods to prepare liposomes. Chemical Engineering Journal. doi:10.1016/j.cej.2019.123106 ![]() |
![]() ![]() | Palazzo, C., Laloy, J., Delvigne, A. S., Nys, G., Fillet, M., Dogne, J. M., Pequeux, C., Foidart, J.-M., Evrard, B., & Piel, G. (2019). Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies. European Journal of Pharmaceutical Sciences, 9 (127), 52-59. doi:10.1016/j.ejps.2018.10.006 ![]() |
Karim, R., Lepeltier, E., Esnaut, L., Pigeon, P., Lepinaox-Chambaud, Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2019). Surface-functionalization with NFL peptide of ferrocifen loaded lipid nanocapsules: preferential entry into human glioblastoma cells [Paper presentation]. 9th International Symposium on Bioorganometalic chemistry, York, United Kingdom. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (19 December 2018). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 1st CIRM Scientific Day, Liège, Belgium. |
![]() ![]() | Coelho Cristino Mamede, L. C., Ledoux, A., Desdemoustier, P., Jansen, O., Piel, G., Fillet, M., De Tullio, P., & Frederich, M. (19 December 2018). Quantitative analysis of a natural compound and heparin by HPLC-DAD and 1H NMR for the characterization of a liposomal formulation [Poster presentation]. The first CIRM scientific Day, Liège, Belgium. |
Penoy, N., Bigazzi, W., Piel, G., & Evrard, B. (19 December 2018). Liposome production by innovative method using supercritical fluids [Paper presentation]. 1st CIRM Scientific Day, liege, Belgium. |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (October 2018). Study of virus-like particles of human papillomavirus in CE [Paper presentation]. In the framework of High-end Foreign Experts program, Guangzhou, China. |
![]() ![]() | Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (August 2018). Assessment of skin penetration of classical and deformable liposomes [Poster presentation]. 12th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany. |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (13 July 2018). Strategies for the identification and quantitation of intact virus-like particles of human papillomavirus in CE [Paper presentation]. 2nd International Symposium on Advances in Pharmaceutical Analysis (APA 2018), Lille, France. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (12 July 2018). Assessment of skin penetration of classical and deformable liposomes [Paper presentation]. First NANOMED EMJMD's Workshop, Paris, France. |
![]() ![]() | Piel, G. (12 July 2018). Barriers and challenges to nanomedicine developments [Paper presentation]. NANOMED EMJMD Workshop, Paris, France. |
Gallez, A., Palazzo, C., Primac, I., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (24 May 2018). Inclusion of 17β-estradiol into liposome : a tool to study the molecular mechanisms of estrogen receptors [Paper presentation]. 8th Meeting on Nuclear Receptors, Lyon, France. |
![]() ![]() | Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. In Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape. ![]() |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (15 March 2018). Analyse de pseudo-particules virales intactes de papillomavirus humain par électrophorèse capillaire : stratégies pour l’identification et la quantification [Paper presentation]. Analytics & Biologics : de la cellule à la petite molécule ?. |
Piel, G., Lechanteur, A., & Cao, M. (17 January 2018). Update on the progresses and development prospects of the unifying theme "nanomedicine" within CIRM [Paper presentation]. CIRM seminar, Liege, Belgium. |
Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Inclusion of 17β-estradiol into liposome prevent the activation of membrane initiated signaling of ERalpha [Poster presentation]. EMBO Workshop/ Nuclear receptors and biological networks, Kolymbari, Greece. |
![]() ![]() | Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials, 8 (5). doi:10.3390/nano8050270 ![]() |
![]() ![]() | Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Piel, G., & Passirani, C. (2018). Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide. Nanoscale. doi:10.1039/c8nr02132e ![]() |
Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Liposomal and drug-in cyclodextrin-in-liposome formulations encapsulating 17β-estradiol prevent the activation of the non-genomic effects of estrogen receptor alpha [Paper presentation]. The 18th world congress of Gynecological Endocrinology, Florence, Italy. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France. |
Cao, M., Karim, R., CATALDO, D., Frederich, M., Evrard, B., & Piel, G. (December 2017). Pulmonary delivery of a liposome formulation encapsulating a natural flavonoid in the treatment of lung cancer [Poster presentation]. Martine Cao, Bordeaux, France. |
![]() ![]() | Karim, R., Palazzo, C., Laloy, J., Delvigne, A.-S., Vanslambrouck, S., Jérôme, C., Lepeltier, E., Orange, F., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (05 November 2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics, 532 (2), 757-768. doi:10.1016/j.ijpharm.2017.04.064 ![]() |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (19 September 2017). Identification and quantitation of intact virus-like particles of human papillomavirus (HPV-VLP) using capillary electrophoresis [Paper presentation]. CE Pharm 2017. |
![]() ![]() | Nys, G., Gallez, A., Kok, M., COBRAIVILLE, G., Servais, A.-C., Piel, G., Pequeux, C.* , & Fillet, M.*. (05 June 2017). Whole blood microsampling for the quantitation of estetrol without derivatization by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 140, 258-265. doi:10.1016/j.jpba.2017.02.060 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Bigazzi, W., Dufour, G., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (June 2017). Interest of cylodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide [Poster presentation]. EuroDrying’2017 – 6th European Drying Conference, Liège, Belgium. |
![]() ![]() | Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain. |
Piel, G. (2017). La nanomédecine: vers les diagnostics et traitements du futur ? [Paper presentation]. Grandes Conférences Verviétoises, Verviers, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (04 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 2nd European Conference on Pharmaceutics: Drug Delivery, Krakow, Poland. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Piel, G., & Hubert, P. (2017). Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.6b01154 ![]() |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (March 2017). Strategies for the identification and quantitation of virus-like particles of human papillomavirus using capillary electrophoresis [Poster presentation]. Analytical Technologies Europe 2017. |
![]() ![]() | Bettonville, V., Nicol, J. T. J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (2017). Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis. Talanta, 175, 325-330. doi:10.1016/j.talanta.2017.07.046 ![]() |
![]() ![]() | Frère, A., Baroni, A., Hendrick, E., Delvigne, A. S., Orange, F., Peulen, O., Dakwar, G., Diricq, J., Dubois, P., Evrard, B., Remaut, K., Braeckmans, K., De Smedt, S., Laloy, J., Dogne, J. M., Feller, G., Mespouilles, L., Mottet, D., & Piel, G. (2017). PEGylated and Functionalized Aliphatic Polycarbonate Polyplex Nanoparticles for Intravenous Administration of HDAC5 siRNA in Cancer Therapy. ACS Applied Materials and Interfaces, 25 (9(3)), 2181-2195. doi:10.1021/acsami.6b15064 ![]() |
Karim, R., Palazzo, C., Lepeltier, E., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Lipid nanocapsule internalization in U87MG human glioblastoma cells: effect of surface-functionalizing FAM-NFL.TBS-40.63 peptide concentration [Poster presentation]. 3rd CDT in Advanced Therapeutics and Nanomedicines School, 5th NanoFar School. |
Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (2017). Study of virus-like particles of human papillomavirus in capillary electrophoresis [Poster presentation]. 33rd International Symposium on Microscale Separations and Bioanalysis (MSB 2017), Noordwijkerhout, Netherlands. |
![]() ![]() | Karim, R., Lepeltier, E., Palazzo, C., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Enhancement of the internalization of lipid nanocapsules in human glioblastoma cells: Effect of surface concentration of NFL peptide [Poster presentation]. 11èmes Journées du Cancéropôle Grand Ouest. |
![]() ![]() | Karim, R., Palazzo, C., Laloy, J., Lepeltier, E., Delvigne, A.-S., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (December 2016). Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France. |
![]() ![]() | Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (December 2016). NEW INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France. |
Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Karim, R., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (28 September 2016). INNOVATIVE INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Paper presentation]. 4th Congress on Innovation in Drug Delivery, Antibes-Juan-Les-Pins, France. |
Lechanteur, A., Furst, T., Evrard, B., DELVENNE, P., Hubert, P., & Piel, G. (27 September 2016). FINDING THE RIGHT BALANCE BETWEEN EFFECTIVENESS, TOXICITY AND VAGINAL DIFFUSION OF siRNA LIPOPLEXES FOR CERVICAL CANCER TREATMENT [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
Karim, R., Palazzo, C., Laloy, J., Delvigne, A. S., Dogne, J. M., Passirani, C., Evrard, B., & Piel, G. (27 September 2016). DEVELOPMENT OF NOVEL CATIONIC AND LIGAND-GRAFTED ANIONIC LIPOSOMES FOR BRAIN-TARGETED DRUG DELIVERY [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
Furst, T., Dakwar, G., zagato, E., Lechanteur, A., Remaut, K., Evrard, B., De Smedt, S., & Piel, G. (26 September 2016). MUCOADHESIVE SPONGES WITH PEGYLATED LIPOPLEXES: TOWARDS A SUSTAINED VAGINAL DELIVERY OF siRNA [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (August 2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493-593. doi:10.1016/j.ejps.2016.08.058 ![]() |
Frère, A., Evrard, B., Mottet, D., & Piel, G. (2016). Polymeric Nanoparticles as siRNA Drug Delivery System for Cancer Therapy: The Long Road to Therapeutic Efficiency. In A. M. Holban & A. Grumezescu (Eds.), Nanoarchitectonics for Smart Delivery and Drug Targeting (pp. 503-540). Elsevier. doi:10.1016/B978-0-323-47347-7.00018-5 ![]() |
![]() ![]() | Furst, T., Bettonville, V., Farcas, E., Frère, A., Lechanteur, A., Evrard, B., Fillet, M., Piel, G., & Servais, A.-C. (2016). Capillary electrophoresis method to determine siRNA complexation with cationic liposomes. Electrophoresis. doi:10.1002/elps.201600249 ![]() |
![]() ![]() | Furst, T., Dakwar, G. R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., & Piel, G. (2016). Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Journal of Controlled Release. doi:10.1016/j.jconrel.2016.06.028 ![]() |
![]() ![]() | Karim, R., Palazzo, C., Evrard, B., & Piel, G. (16 February 2016). Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Journal of Controlled Release, 10 (227), 23-37. doi:10.1016/j.jconrel.2016.02.026 ![]() |
Palazzo, C., Karim, R., Evrard, B., & Piel, G. (2016). DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER. In A. Grumezescu (Ed.), Nanobiomaterials in drug delivery. Elsevier. doi:10.1016/B978-0-323-42866-8.00001-0 |
Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. European Nanomedicine Meeting, Grenoble, France. |
Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (23 November 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. Biopharmacy Day, Leuven, Belgium. |
Palazzo, C., Karim, R., Furst, T., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (25 October 2015). LIPOSOME ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, FLA, United States. |
Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., Evrard, B., & Piel, G. (08 September 2015). Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma [Poster presentation]. 'From drug development to target drug'- UniGR workshop on Biomedicine, Arlon, Belgium. |
Piel, G. (07 September 2015). Nanomedecine: “Understanding and overcoming major barriers in cancer nanomedicine" [Paper presentation]. UniGR Workshop "Drug Development", Arlon, Belgium. |
Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mottet, D., & Piel, G. (September 2015). Polyplexes Based on Polycarbonate Polymers and HDAC5 siRNA Efficiently Decrease the Proliferation of Cancer Cells [Poster presentation]. UniGR biomedecine workshop, Arlon, Belgium. |
![]() ![]() | Palazzo, C., Karim, R., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (02 June 2015). Liposome Encapsulating Estetrol For The Treatment Of Ischemia Diseases In Prematures Babies [Poster presentation]. Biomedica 2015, Genk, Belgium. |
Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (02 June 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Poster presentation]. Biomedica 2015, Genk, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (28 May 2015). DEVELOPMENT OF LIPOPLEXES FOR A TOPICAL TREATMENT OF HPV16 INDUCED LESIONS: In vitro and ex vivo studies [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberg, Belgium. |
Frère, A., Evrard, B., Mottet, D., & Piel, G. (28 May 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (13 May 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of HPV16 induced lesions [Paper presentation]. GIGA-Cancer Day 2015, Liege, Belgium. |
Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (17 April 2015). Liposomes entrapping apigenin for the treatment of glioblastoma [Poster presentation]. 2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom. |
![]() ![]() | Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (14 April 2015). LIPOSOME CONTAINING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 1st European Conference on Pharmaceutics, Reims, France. |
Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (14 April 2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma [Poster presentation]. 1st European conference on Pharmaceutics Reims 2015, Reims, France. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (14 April 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics Drug Delivery, Reims, France. |
Furst, T., Lechanteur, A., Evrard, B., & Piel, G. (13 April 2015). Mucoadhesive hydroxyethyl-cellulose sponges as lipoplexes delivery system for vaginal application [Poster presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France. |
![]() ![]() | Lechanteur, A.* , Furst, T.* , Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (16 February 2015). Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. International Journal of Pharmaceutics, 483, 268-277. doi:10.1016/j.ijpharm.2015.02.041 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (11 February 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of cervical (pre)neoplastic lesions [Poster presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium. |
![]() ![]() | Furst, T., Piette, M., Lechanteur, A., Evrard, B., & Piel, G. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2015.01.019 ![]() |
![]() ![]() | Dufour, G., Bigazzi, W., Wong, N., Boschini, F., De Tullio, P., Piel, G., CATALDO, D., & Evrard, B. (2015). Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. International Journal of Pharmaceutics, 495 (2), 869-878. doi:10.1016/j.ijpharm.2015.09.052 ![]() |
![]() ![]() | Karim, R., Palazzo, C., Dubois, N., Frère, A., Bours, V., Passirani, C., Evrard, B., & Piel, G. (2015). Design of Liposomes Entrapping Apigenin- A Novel Approach for Glioblastoma Therapy [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States. |
![]() ![]() | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France. |
![]() ![]() | Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Hendrick, E., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2015). Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability. Biomacromolecules. doi:10.1021/bm501676p ![]() |
Dufour, G., Piel, G., & Evrard, B. (2015). Utilisation et caractérisation des complexes de cyclodextrines dans les formulations à usage pharmaceutique. In N. Morin-Crini, S. Fourmentin, ... G. Crini, Cyclodextrines: Histoire, propriétés, chimie et applications. Presses universitaires de Franche-Comté. ![]() |
Frère, A., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (12 December 2014). Polyplex based on polycarbonate polymers for an efficient delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands. |
Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (12 December 2014). Estetrol and cyclodextrin-estetrol loaded liposomes for the treatment of ischemia diseases in premature babies [Poster presentation]. Biopharmacy Day, Vlaardingen, Netherlands. |
![]() ![]() | Furst, T., & Piel, G. (12 December 2014). MUCOADHESIVE HYDROXYETHYL-CELLULOSE SPONGES AS DELIVERY SYSTEM FOR VAGINAL APPLICATION [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal. |
![]() ![]() | Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France. |
![]() ![]() | De Bleye, C., Dumont, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (23 June 2014). Development of a multiplexed surface-enhanced Raman scattering quantitative approach for bisphenols detection [Paper presentation]. Drug Analysis 2014, Liège, Belgium. |
Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (26 May 2014). Impact of the Structure of Biocompatible Aliphatic Polycarbonate on siRNA Transfection Ability [Poster presentation]. Advanced Functional Polymers for Medicine AFPM) 2014, Liège, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014. |
![]() ![]() | De Bleye, C., Dumont, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (15 May 2014). Development of an analytical method to detect simultaneously bisphenols using a multiplexed surface-enhanced Raman scattering quantitative approach [Poster presentation]. The Bioforum 2014 of BioLiège, Liège, Belgium. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal. |
Frère, A., Peixoto, P., Kawalec, M., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (April 2014). Polyplexes Targeting Angiogenesis in Cancer [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceuticsand Pharmaceutical Technology, Lisbon, Portugal. |
![]() ![]() | De Bleye, C.* , Sacre, P.-Y.* , Dumont, E., Netchacovitch, L., Chavez, P.-F., Piel, G., Lebrun, P., Hubert, P., & Ziemons, E. (05 March 2014). Development of a quantitative approach using surface-enhanced Raman chemical imaging: First step for the determination of an impurity in a pharmaceutical model. Journal of Pharmaceutical and Biomedical Analysis, 90, 111-118. doi:10.1016/j.jpba.2013.11.026 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014. |
![]() ![]() | De Bleye, C., Sacre, P.-Y., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Lebrun, P., Hubert, P., & Ziemons, E. (20 January 2014). Quantitative approaches based on Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Raman Chemical Imaging (SER-CI) [Paper presentation]. Forum des jeunes chercheurs, Liège, Belgium. |
![]() ![]() | Frère, A., Krier, F., Evrard, B., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States. |
![]() ![]() | Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium. |
Piel, G. (2014). Interest of using lipid vesicular systems for dermatological applications [Paper presentation]. 2nd NANODRUG workshop, Bruxelles, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France. |
![]() ![]() | Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France. |
Frère, A., Kawalec, M., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2013). The intracellular fate of polycarbonate Polyplexes modulates the efficacy of siRNA [Poster presentation]. 28th GTRV annual meeting, Orleans, France. |
![]() ![]() | De Bleye, C., Dumont, E., Rozet, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (15 November 2013). Determination of 4-aminophenol in a pharmaceutical formulation using Surface Enhanced Raman scattering: from development to method validation. Talanta, 116, 899-905. doi:10.1016/j.talanta.2013.07.084 ![]() |
![]() ![]() | Frère, A., Peixoto, P., Mottet, D., & Piel, G. (17 October 2013). Polyplexes based on polycarbonate polymers and siRNA against HDAC7 for a targeted anti-angiogenic therapy [Paper presentation]. 17th forum of Pharmaceutical Sciences, Spa, Belgium. |
![]() ![]() | De Bleye, C., Sacre, P.-Y., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Lebrun, P., Hubert, P., & Ziemons, E. (17 October 2013). Development of a quantitative approach based on surface-enhanced Raman chemical imaging (SER-CI) [Paper presentation]. Belgian Society of Pharmaceutical Sciences, Spa, Belgium. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques. |
![]() ![]() | De Bleye, C., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Dumont, E., Rozet, E., Piel, G., Hubert, P., & Ziemons, E. (July 2013). Chemical imaging of small molecules from simple to complex matrices: Quantitative approaches based on Surface Enhanced Raman scattering [Paper presentation]. Symposium on Pharmaceutical and Biomedical Analysis 2013 (PBA 2013), Bologna, Italy. |
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 June 2013). Développement et optimisation de vecteur de type lipoplexe pour une approche thérapeutique antisens dans le cadre de lésions induites par HPV [Paper presentation]. Séminaire C.I.R.M. |
Frère, A., & Piel, G. (22 April 2013). Développement de vecteurs polymériques de type polyplexes à base de nouveaux polymères cationiques biodégradables de type polycarbonates et de siRNA dirigés spécifiquement contre l’histone déacétylase 7 [Paper presentation]. Séminaire du Centre Interfacultaire de Recherche du Médicament (C.I.R.M.), Liège, Belgium. |
![]() ![]() | De Bleye, C., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Sacre, P.-Y., Hubert, P., & Ziemons, E. (18 April 2013). Development of quantitative approaches based on Surface Enhanced Raman Scattering chemical imaging [Poster presentation]. The bioforum 2013 of BioLiège, Liège, Belgium. |
Piel, G. (2013). POLYMERIC NANOVECTORS: Actual developments and perspectives [Paper presentation]. Séminaires de Chimie, ULg. |
![]() ![]() | Reschner, A., Shim, Y. H., Dubois, P., Delvenne, P., Evrard, B., Marcelis, L., Moucheron, C., Kirsch-De Mesmaeker, A., Defrancq, E., Raes, M., Piette, J., Collard, L., & Piel, G. (2013). Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate)-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene. Journal of Biomedical Nanotechnology, 9, 1-9. doi:10.1166/jbn.2013.1634 ![]() |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium. |
Piel, G. (2013). Nanovecteurs polymériques et lipidiques pour le traitement du cancer: développements en cours et perspectives [Paper presentation]. Séminaires et Conférences du Louvain Drug Research Institute et de l'Ecole doctorale en sciences pharmaceutiques. |
![]() ![]() | Zime-Diawara, H., Gbaguidi, F., Semde, R., Some, I., Quetin-Leclercq, J., Moudachirou, M., Piel, G., & Evrard, B. (2013). Effect of cyclodextrins on artemisinin stability and in vitro dissolution. International Journal of Biological and Chemical Sciences, 7 (1), 356-365. ![]() |
Evrard, B., & Piel, G. (2012). Le double défi de la nanomédecine [Paper presentation]. Liège Créative, Liege, Belgium. |
Piel, G., & Evrard, B. (29 November 2012). Le double défi de la nanomédecine [Paper presentation]. Liègre Créative. |
![]() ![]() | Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium. |
![]() ![]() | Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France. |
![]() ![]() | Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France. |
![]() ![]() | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France. |
![]() ![]() | Zime Diawara, H., Dive, G., Piel, G., Moudachirou, M., Quetin-Leclercq, J., Frederich, M., & Evrard, B. (2012). UNDERSTANDING THE INTERACTIONS BETWEEN ARTEMISININ AND CYCLODEXTRINS: SPECTROSCOPIC STUDIES AND MOLECULAR MODELING. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 74 (1), 305-315. doi:10.1007/s10847-012-0117-9 ![]() |
Reschner, A., Shim, Y. H., Dubois, P., Evrard, B., DELVENNE, P., Marcelis, L., Moucheron, C., Kirsch Demmesmacher, A., Defrancq, E., Raes, M., Collard, L., & Piel, G. (2012). EVALUATION OF A NEW BIOCOMPATIBLE POLY(N-(MORPHOLINO ETHYL METHACRYLATE)-BASED COPOLYMER FOR THE DELIVERY OF Ruthenium oligonucleotides, targeting HPV16 E6 oncogene [Poster presentation]. GTRV, Paris, France. |
![]() ![]() | Van Overstraeten-Schlögel, N., Shim, Y. H., Tevel, V., Piel, G., Piette, J., Dubois, P., & Raes, M. (2012). Assessment of new biocompatible Poly(N-(morpholino)ethyl methacrylate)-based copolymers by transfection of immortalized keratinoc. Drug Delivery, 16 (2), 102-111. ![]() |
Ducat, E., Deprez, J., Noël, A., Evrard, B., Peulen, O., & Piel, G. (06 December 2011). NUCLEAR DELIVERY OF A THERAPEUTIC PEPTIDE BY LONG CIRCULATING pH-SENSITIVE LIPOSOMES: BENEFITS OVER CLASSICAL VESICLES [Poster presentation]. XXVIth Scientific GTRV meeting, Bruxelles, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (14 June 2011). Topical application of liposomes: parameters influencing their effectiveness [Poster presentation]. PharmSciFair, Prague, Czechia. |
![]() ![]() | Gillet, A., Compère, P., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (June 2011). Liposome surface charge influence on skin penetration behaviour. International Journal of Pharmaceutics, 411 (1-2), 223-231. doi:10.1016/j.ijpharm.2011.03.049 ![]() |
![]() ![]() | Piel, G. (20 May 2011). Nanotechnology based anti-cancer drug delivery systems: current developments and perspectives [Paper presentation]. GIGA cancer day 2011, Liège, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (12 May 2011). Parameters influencing the skin penetration effectiveness of liposomes [Paper presentation]. 15th Forum of Pharmaceutical Sciences, Spa, Belgium. |
Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (28 March 2011). Evaluation of parameters affecting skin penetration behaviour of liposomes [Poster presentation]. Skin Forum 12th Annual Meeting, Frankfurt, Germany. |
Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (25 March 2011). Peptide-loaded pH-sensitive Liposomes: effective penetration of Print3G in the nucleus of cancer cells [Paper presentation]. BIT's 4th annual protein and peptide conference, Pékin, China. |
![]() ![]() | Grammenos, A., Joset, A., Leyh, B., Piel, G., & Hoebeke, M. (2011). A combination of ESR and SANS techniques to explore the cyclodextrin action on membranes. Current Medicinal Chemistry, 76. ![]() |
![]() ![]() | Ducat, E., Evrard, B., Peulen, O., & Piel, G. (2011). Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry. Journal of Drug Delivery Science and Technology, 21 (6), 469-477. doi:10.1016/S1773-2247(11)50076-0 ![]() |
![]() ![]() | Gillet, A., Evrard, B., & Piel, G. (January 2011). Liposomes and parameters affecting their skin penetration behaviour. Journal of Drug Delivery Science and Technology, 21, 35-42. doi:10.1016/S1773-2247(11)50004-8 ![]() |
![]() ![]() | Ducat, E., Deprez, J., Gillet, A., Noël, A., Evrard, B., Peulen, O.* , & Piel, G.*. (2011). Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: Benefits over classical vesicles. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2011.08.034 ![]() * These authors have contributed equally to this work. |
Piel, G., & Bochot, A. (2011). Applications of cyclodextrins for skin formulation and delivery. In E. Bilensoy (Ed.), Cyclodextrins in pharmaceutics, cosmetics and biomedicine. Wiley. doi:10.1002/9780470926819.ch9 |
![]() ![]() | Berton, A., Piel, G., & Evrard, B. (2011). Powdered lipid nano and microparticles : production and applications. Recent Patents on Drug Delivery and Formulation, 5 (3), 188-200. doi:10.2174/187221111797200588 ![]() |
![]() ![]() | Gillet, A., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (2011). Skin penetration behaviour of liposomes as a function of their composition. European Journal of Pharmaceutics and Biopharmaceutics, 79, 43-53. doi:10.1016/j.ejpb.2011.01.011 ![]() |
![]() ![]() | Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (December 2010). Cellular uptake of long-circulating pH-sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells. Drug Discovery Today, 15 (23-24), 1079-1114. doi:10.1016/j.drudis.2010.09.362 ![]() |
Piel, G. (29 October 2010). Traitements topiques du psoriasis [Paper presentation]. Journée Mondiale du Psoriasis, Liège, Belgium. |
![]() ![]() | Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (October 2010). PEPTIDE-LOADED LIPOSOMES AGAINST BREAST CANCER: EFFECTIVE PENETRATION IN CELLS OF LONG CIRCULATING pH-SENSITIVE VESICLES [Poster presentation]. 2nd conference on "Innovation in Drug Delivery: From Preformulation to Development through Innovative Evaluation Process", Aix-en-Provence, France. |
Piel, G., Collard, L., Evrard, B., Delvenne, P., Dubois, P., & Reschner, A. (October 2010). POLYPLEXES TARGETING E6: OPTIMIZATION OF THE FORMULATIONS IN TERMS OF TRANSFECTION, TOXICITY AND EFFICIENCY [Poster presentation]. 2nd Conference Innovation in Drug Delivery: From Preformulation to development through Innovative Evaluation Process, Aix en Provence, France. |
Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (October 2010). Interest of vesicular systems in dermal drug delivery [Poster presentation]. 2nd Innovation in Drug Delivery, Aix-en-Provence, France. |
Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (06 July 2010). Penetration mechanism of classical and deformable liposomes through pig ear skin [Poster presentation]. Skin Forum 11th Annual Meeting, Edinburgh, United Kingdom. |
![]() ![]() | Grammenos, A., Mouithys-Mickalad, A., Guelluy, P.-H., Lismont, M., Piel, G., & Hoebeke, M. (2010). ESR technique for non invasive way to quantify cyclodextrins effect on cell membranes. Biochemical and Biophysical Research Communications, 1-5. doi:10.1016/j.bbrc.2010.06.050 ![]() |
![]() ![]() | Ducat, E., Brion, M., Lecomte, F., Evrard, B., & Piel, G. (June 2010). The experimental design as practical approach to develop and optimize a formulation of peptide-loaded liposomes. AAPS PharmSci, 11 (2), 966-975. doi:10.1208/s12249-010-9463-3 ![]() |
Grammenos, A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (10 May 2010). IESR spectroscopy: an easy and non invasive way to determine the extraction power of beta-Cyclodextrins on membranes [Paper presentation]. 15th International cyclodextrin symposium, Vienne, Austria. |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 April 2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin [Paper presentation]. Perspectives in Percutaneous Penetration 2010 12th International Conference, La Grande Motte, France. |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (29 March 2010). Classical and deformable liposomes: possible mechanism of penetration through pig ear skin [Poster presentation]. 8th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany. |
![]() ![]() | Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (26 January 2010). Développement et validation d'une méthode de dosage de la glucosamine par SPE/LC/MS dans le plamsa canin [Paper presentation]. Forum des jeunes chercheurs du C.I.R.M, Liège, Belgium. |
![]() ![]() | Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (2010). Development and validation of a sensitive solid phase extraction/hydrophilic interaction liquid chromatography/mass spectrometry method for the accurate determination of glucosamine in dog plasma. Journal of Chromatography. A, 1217, 3275-3281. doi:10.1016/j.chroma.2010.01.024 ![]() |
![]() ![]() | Castagne, D., Dive, G., Evrard, B., Frederich, M., & Piel, G. (2010). Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Journal of Pharmacy and Pharmaceutical Sciences, 13 (2), 362-377. doi:10.18433/j3bs34 ![]() |
![]() ![]() | Dehousse, V., Garbacki, N., Jaspart, S., Castagne, D., Piel, G., Colige, A., & Evrard, B. (2010). Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. International Journal of Biological Macromolecules, 46, 342-349. doi:10.1016/j.ijbiomac.2010.01.010 ![]() |
![]() ![]() | Castagne, D., Evrard, B., Nusgens, B., & Piel, G. (2010). Effect of β-cyclodextrin and its derivatives on caveolae disruption, relationships with their cholesterol extraction capacities. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 67, 369-376. doi:10.1007/s10847-009-9718-3 ![]() |
![]() ![]() | Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin. Journal of Pharmacy and Pharmacology, 62 (6), 788-807. ![]() |
Ducat, E., Deprez, J., Neuville, N., Peulen, O., Evrard, B., & Piel, G. (2010). Long-circulating liposomes: comparison between pH-sensitive and standard vesicles in terms of cellular uptake [Paper presentation]. 7th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, La Valette, Malta. |
![]() ![]() | Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (01 December 2009). Développement et validation d'une méthode de dosage de la glucosamine par SPE/HILIC/MS dans le plamsa de chien [Poster presentation]. 8ème congrès francophone de l'AfSep sur les sciences séparatives et les couplages, Marseille, France. |
![]() ![]() | Brion, M., Jaspart, S., Perrone, L., Piel, G., & Evrard, B. (November 2009). The supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design. Journal of Supercritical Fluids, 51 (1), 50-56. doi:10.1016/j.supflu.2009.06.021 ![]() |
![]() ![]() | Gillet, A., Grammenos, A., Compère, P., Evrard, B., & Piel, G. (01 October 2009). Development of a new topical system: Drug-in-cyclodextrin-in-deformable liposome. International Journal of Pharmaceutics, 380 (1-2), 174-180. doi:10.1016/j.ijpharm.2009.06.027 ![]() |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Paper presentation]. PharmSciFair, Nice, France. |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (07 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Poster presentation]. PharmSciFair, Nice, France. |
Castagne, D., Frederich, M., Evrard, B., Nusgens, B., Dive, G., & Piel, G. (June 2009). Studies for understanding the interactions between biological membranes and cyclodextrins and their effects at the cell level [Poster presentation]. 2nd PharmSciFair, Nice, France. |
![]() ![]() | Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. 2nd Pharmaceutical Sciences Fair and Exhibition - PharmSciFair 2009, Nice, Belgium. |
![]() ![]() | Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. Pre-Satellite Young Scientists Meeting, nice, France. |
Gillet, A., Grammenos, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (14 May 2009). Betamethasone in cyclodextrin in deformable liposomes for cutaneous applications: development and diffusion studies [Paper presentation]. Quatorzième Forum des Sciences Pharmaceutiques, Blankenberge, Belgium. |
Piel, G. (23 April 2009). La préparation magistrale dermatologique [Paper presentation]. Colloque de Dermatologie, Liège, Belgium. |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (01 April 2009). Betamethasone in cyclodextrin in deformable liposomes for topical applications: absorption studies using pig skin [Poster presentation]. Biomedica, Liège, Belgium. |
Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 March 2009). development and validation of a SPE-LC-UV method for the determination of betamethasone in pig skin [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France. |
Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (09 March 2009). Development of a new cutaneous delivery system: drug in cyclodextrin in deformable liposomes [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France. |
Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (03 February 2009). Mise au point de liposomes déformables contenant de la bétamethasone encapsulée sous forme de complexes dans des cyclodextrines dans le but d'une application dermatologique [Paper presentation]. Forum des Jeunes Chercheurs, Liège, Belgium. |
Krier, F., Evrard, B., Piel, G., & Riva, R. (03 February 2009). Développement d'un implant intra-péritonéal contre l'endométriose [Paper presentation]. Forum des Jeunes Chercheurs du CIRM, Liège, Belgium. |
![]() ![]() | Grammenos, A., Bahri, M. A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (2009). Quantification of Randomly-methylated-b-cyclodextrin effect on liposome: An ESR study. Biochemical and Biophysical Research Communications, 390, 5-9. doi:10.1016/j.bbrc.2009.08.172 ![]() |
Grammenos, A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (2009). Quantification of cholesterol extraction and microviscosity modifications involved by cyclodextrin on HCT116 cells [Poster presentation]. Biomedica, liège, Belgium. |
Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Biomedica, Liège, Belgium. |
Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Pharmscifair, Nice, France. |
Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). FORMULATION OF PEPTIDE-LOADED LIPOSOMES FOR INTRAVENOUS DELIVERY: OPTIMIZATION OF THE ENCAPSULATION EFFICIENCY [Paper presentation]. 14th forum of pharmaceutical sciences, Blankenberge, Belgium. |
Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CARACTERISATION ET OPTIMISATION DE L’ENCAPSULATION D’UN PEPTIDE ANTAGONISTE D’ONCOPROTEINE AU SEIN DE LIPOSOMES PEGYLES [Paper presentation]. Forum des jeunes chercheurs. |
![]() ![]() | Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (2009). Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 63 (3-4), 225-231. doi:10.1007/s10847-008-9510-9 ![]() |
Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (26 November 2008). Caractérisation et étude de diffusion in vitro de liposomes deformables contenant de la bétaméthasone encapsulée sous la forme de complexes dans des cyclodextrines [Poster presentation]. 11 émes Journées du Club Français des Cyclodextrines, Rouen, France. |
Castagne, D., Frederich, M., Dive, G., Evrard, B., & Piel, G. (November 2008). Etude par modélisation moléculaire et spectroscopie RMN des interactions entre le cholestérol et les cyclodextrines afin de comprendre leurs effets sur les membranes cellulaires [Paper presentation]. 11èmes Journées du Club français des Cyclodextrines, Rouen, France. |
Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (10 October 2008). Betamethasone in cyclodextrin in deformable liposomes, a new cutaneous delivery system: characterization and in vitro diffusion studies [Paper presentation]. European IP-Galenos Course- Skin barrier Function: Cutaneous absoprtion and environmental factors, Lyon, France. |
Grammenos, A., Bahri, M. A., Piel, G., & Hoebeke, M. (16 May 2008). Impact of a cyclodextrin on liposome sans cells : ESR evidence [Poster presentation]. Sixteenth Meeting of the Benelux EPR Group, Gent, Belgium. |
Grammenos, A., Leyh, B., Piel, G., Bahri, M. A., & Hoebeke, M. (09 May 2008). Impact of randomly-methylated-beta- cyclodextrin on DMPC liposomes and cell [Paper presentation]. 14th International cyclodextrin symposium, Kyoto, Japan. |
Castagne, D., Blacher, S., Alvarez Gonzalez, M.-L., Berndt, S., Piette, M., Evrard, B., Nusgens, B., Noël, A., & Piel, G. (May 2008). Effect of b-cyclodextrin and its methylated derivatives on the ex-vivo rat aortic ring angiogenesis assay [Poster presentation]. XIIth BELACT Meeting, Namur, Belgium. |
Castagne, D., Fillet, M., Evrard, B., Nusgens, B., & Piel, G. (April 2008). Determination of the ideal cyclodextrin concentrations to study their effect in the lipid rafts by the use of cholesterol extraction and cell viability studies in endothelial cells [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain. |
![]() ![]() | Barillaro, V., Dive, G., Ziemons, E., Bertholet, P., Evrard, B., Delattre, L., & Piel, G. (10 February 2008). Theoretical and Experimental Vibrational Study of Miconazole and Its Dimers with Organic Acids: Application to the IR Characterization of Its Inclusion Complexes with Cyclodextrins. International Journal of Pharmaceutics, 350 (1-2), 155-165. doi:10.1016/j.ijpharm.2007.08.048 ![]() |
![]() ![]() | Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Frederich, M., Ziemons, E., & Piel, G. (22 January 2008). Theoretical and Experimental Investigations of Organic Acids/Cyclodextrin Complexes and Their Consequences Upon the Formation of Miconazole/Cyclodextrin/Acid Ternary Inclusion Complexes. International Journal of Pharmaceutics, 347 (1-2), 62-70. doi:10.1016/j.ijpharm.2007.06.030 ![]() |
Ducat, E., Evrard, B., & Piel, G. (2008). STUDY OF PEGYLATED LIPOSOMES CRYOPROTECTION IN TERMS OF RETENTION EFFICIENCY [Poster presentation]. 6th international workshop on drug delivery systems for nanomedecines, Liblice, Czechia. |
![]() ![]() | Krier, F., Nizet, D., Riva, R., Mestdagt, M., Frankenne, F., Jérôme, C., Piel, G., & Evrard, B. (2008). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Poster presentation]. 6th World Meeting on Pharmaceutics, biopharmaceutics and pharmaceutical technology, Barcelone, Spain. |
Grammenos, A., Leyh, B., Joset, A., Piel, G., Bahri, M. A., & Hoebeke, M. (November 2007). Etude de la Rameb par resonance paramagnétique électronique et diffusion de neutrons aux petits angles [Paper presentation]. 10ème journée du club français des cyclodextrines, Lens, France. |
Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (November 2007). Interaction de la b-cyclodextrine et de ses dérivés avec des cellules endothéliales: dosage du cholestérol résiduel [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France. |
![]() ![]() | Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy. |
Castagne, D., Delattre, L., Evrard, B., Fillet, M., Nusgens, B., & Piel, G. (October 2007). Cell membrane destructuration using cyclodextrins: effect on cholesterol content of endothelial cells [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (October 2007). Characterization of siRNA lipoplexes in terms of size and zeta potential data [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy. |
Grammenos, A., Piel, G., Bahri, M. A., & Hoebeke, M. (September 2007). Electron spin resonance study: the drug impact on membrane viscosity [Poster presentation]. 12th European Conference on the Spectroscopy of Biological Molecules, Bobigny, France. |
![]() ![]() | Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015 ![]() |
![]() ![]() | Tursilli, R., Piel, G., Delattre, L., & Scalia, S. (June 2007). Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. European Journal of Pharmaceutics and Biopharmaceutics, 66 (3), 483-487. doi:10.1016/j.ejpb.2007.02.017 ![]() |
![]() ![]() | Piette, M., Castagne, D., Delattre, L., & Piel, G. (April 2007). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 101-103. doi:10.1007/s10847-006-9214-y ![]() |
Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (April 2007). Evaluation of the cytotoxicity of cyclodextrins on endothelial cells using MTT assay [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands. |
Grammenos, A., Bahri, M. A., Piel, G., Votion, D., & Hoebeke, M. (April 2007). Electron Spin Resonance study : The impact of food or drug on membrane viscosity [Poster presentation]. Biomedica. |
![]() ![]() | Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y ![]() |
![]() ![]() | Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006 ![]() |
Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France. |
![]() ![]() | Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z ![]() |
Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (2007). Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurement [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Krier, F., Nizet, D., Riva, R., colombo, M., Frankenne, F., Jérôme, C., Piel, G., Delattre, L., & Evrard, B. (2007). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Grammenos, A., Leyh, B., Joset, A., Piel, G., Bahri, M. A., & Hoebeke, M. (2007). Etude de la Rameb par résonance paramagnétique électronique (RPE) et diffusion de neutrons aux petits angles (SANS) [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France. |
Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
![]() ![]() | Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Ziemons, E., & Piel, G. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. International Journal of Pharmaceutics, 342 (1-2), 152-160. doi:10.1016/j.ijpharm.2007.05.003 ![]() |
![]() ![]() | Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (2007). Effect of cyclodextrins on the viability of endothelial cells. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 105-107. doi:10.1007/s10847-006-9211-1 ![]() |
![]() ![]() | Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France. |
![]() ![]() | Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011 ![]() |
Piette, M., Castagne, D., Delattre, L., & Piel, G. (May 2006). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes [Poster presentation]. 13th International Cyclodextrin Symposium, Turin, Italy. |
![]() ![]() | Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044 ![]() |
Barillaro, V., Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (2006). Application of supercritical carbon dioxide to the preparation of inclusion complexes into cyclodextrins [Paper presentation]. 13th International Pharmaceutical Technology Symposium, Antalya, Turkey. |
Tursilli, R., Scalia, S., Piel, G., Jaspart, S., & Delattre, L. (2006). Encapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France. |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy. |
Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France. |
Barillaro, V., Bertholet, P., Evrard, B., Delattre, L., Dive, G., & Piel, G. (September 2005). Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: effect of acidic ternary compound and molecular modelling study [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy. |
Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy. |
Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France. |
![]() ![]() | Piel, G., Boulmedarat, L., Bochot, A., Lesieur, S., Delattre, L., & Fattal, E. (June 2005). Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmaceutical Research, 22 (6), 962-971. doi:10.1007/s11095-005-4591-2 ![]() |
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France. |
![]() ![]() | Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042 ![]() |
Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France. |
Bahri, M. A., Hambach, L., Piel, G., Seret, A., & Hoebeke, M. (March 2005). ESR quantification of liposome membrane microviscosity change induced by the addition of cholesterol and drugs [Poster presentation]. 38th Annual International Meeting of the Electron Spin Resonance Group of the Royal Society of Chemistry, Advanced Techniques and Applications of EPR, Bath, United Kingdom. |
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France. |
![]() ![]() | Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75 ![]() |
![]() ![]() | Bertholet, P., Guéders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Piel, G., Delattre, L., & Evrard, B. (2005). The Effect of Cyclodextrins on the Aqueous Solubility of a New Mmp Inhibitor: Phase Solubility, 1 H-Nmr Spectroscopy and Molecular Modeling Studies, Preparation and Stability Study of Nebulizable Solutions. Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175. ![]() |
![]() ![]() | Barillaro, V., Evrard, B., Delattre, L., & Piel, G. (2005). Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS Journal, 7 (1), 149-E155. doi:10.1208/aapsj070116 ![]() |
Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (2005). Evaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins. In Journal of inclusion Phenomena and Macrocyclic Chesmistry. ![]() |
Hoebeke, M., Bahri, M. A., Grammenos, A., & Piel, G. (2005). ESR evidence of cholesterol extraction from liposome and cell membrane induced by RAMEB [Paper presentation]. General Congress of the SFP and BPS, Lille, France. |
![]() ![]() | Barillaro, V., Bertholet, P., Henry de Hassonville, S., Ziemons, E., Evrard, B., Delattre, L., & Piel, G. (30 November 2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. Journal of Pharmacy and Pharmaceutical Sciences, 7 (3), 378-388. ![]() |
![]() ![]() | Henry de Hassonville, S., Chiap, P., Liégeois, J.-F., Evrard, B., Delattre, L., Crommen, J., Piel, G., & Hubert, P. (21 September 2004). Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 133-143. doi:10.1016/j.jpba.2004.05.023 ![]() |
![]() ![]() | Piel, G., Boulmedarat, L., Bochot, A., Delattre, L., & Fattal, E. (May 2004). Influence of methyl-b-cyclodextrin on the relase kinetics of inulin encapsulated in bioadhesive liposomes [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (May 2004). Effect of methylated-b-cyclodextrin on the skin and influence on cyproterone acetate percutaneous absorption [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (May 2004). Evaluation of the pulmonary inflammation and the bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins [Paper presentation]. XII th International Cyclodextrin Symposium, Montpellier, France. |
![]() ![]() | Henry de Hassonville, S., Dive, G., Evrard, B., Barillaro, V., Bertholet, P., Delattre, L., & Piel, G. (2004). Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives. Journal of Drug Delivery Science and Technology, 14 (5, SEP-OCT), 357-362. doi:10.1016/s1773-2247(04)50064-3 ![]() |
![]() ![]() | Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2 ![]() |
![]() ![]() | Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010 ![]() |
Hambach, L., Bahri, M. A., Piel, G., & Hoebeke, M. (2004). ESR quantification of DMPC liposome viscosity change by the addition of cholesterol and/or cyclodextrin [Paper presentation]. 12th meeting of the Benelux EPR Society, Antwerp, Belgium. |
![]() ![]() | Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004 ![]() |
Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (January 2004). Etude des interactions cyclodextrines-liposomes: modification de la cinétique de libération de l'inuline encapsulée dans des lioposomes bioadhésifs en présence de méthyl-b-cyclodextrine [Paper presentation]. 7èmes Journées du Club français des Cyclodextrines, Lille, France. |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2004). La Rameb, un promoteur d’absorption cutanée pour l’acétate de cypro-térone ? [Paper presentation]. 7e journées du club cyclodextrines, Lille, France. |
![]() ![]() | Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (October 2003). The skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Poster presentation]. Skin and Formulation, 1st Symposium, Paris, France. |
![]() ![]() | Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8 ![]() |
Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium. |
Roland, I., Piel, G., Delattre, L., & Evrard, B. (May 2003). Systematic characterization of oil-in-water emulsion for formulation design [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Bertholet, P., Cataldo, D., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., & Evrard, B. (May 2003). Effect of inhaled cyclodextrins on the pulmonary inflammation and bronchial hyperresponsiveness in mice [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Henry de Hassonville, S., Dive, G., Prosperi, C., Perly, B., Piel, G., Barillaro, V., Bertholet, P., Delattre, L., Llabres, G., & Evrard, B. (May 2003). Influence of cyclodextrins on the solubility and the stability of cyproterone acetate [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (May 2003). An ex-vivo study of the skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2003). Cyclodextrins as topical permeation enhancers : in vitro and in vivo testing [Poster presentation]. Symposium skin and formulation APGI, Paris, France. |
Barillaro, V., Van Hees, T., Bertini, S., Piel, G., Bertholet, P., Henry de Hassonville, S., Evrard, B., & Delattre, L. (January 2003). Etude de l'inclusion du miconazole dans les cyclodextrines par le CO2 supercritique: caracterisation des complexes par HPLC, CP-MAS-NMR et FT-IR [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (January 2003). Etude comparative de la tolérance cutanée de nouveaux dérivés amphiphiles de cyclodextrines: les phospholipidyl-cyclodextines [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
Bertholet, P., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (January 2003). Etude de l'hyperactivité bronchique induite par l'administration pulmonaire de cyclodextrines chez la souris [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France. |
![]() ![]() | Evrard, B., Chiap, P., De Tullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., & Delattre, L. (13 December 2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release, 85 (1-3), 45-50. doi:10.1016/S0168-3659(02)00270-5 ![]() |
![]() ![]() | Van Hees, T., Barillaro, V., Piel, G., Bertholet, P., De Hassonville, S., Evrard, B., & Delattre, L. (December 2002). Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44 (1-4), 271-274. doi:10.1023/A:1023084617964 ![]() |
![]() ![]() | Van Hees, T., Piel, G., Henry de Hassonville, S., Evrard, B., & Delattre, L. (May 2002). Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. European Journal of Pharmaceutical Sciences, 15 (4), 347-353. doi:10.1016/S0928-0987(02)00018-0 ![]() |
Piel, G., Moutard, S., Van Hees, T., Henry de Hassonville, S., Delattre, L., & Evrard, B. (April 2002). Determination of the interaction between cyclodextins and drugs: comparison of two methods (phase solubility diagrams and NMR) [Poster presentation]. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, Italy. |
Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Barillaro, V., Betholet, P., Evrard, B., & Delattre, L. (February 2002). Augmentation de la solubilité de l'acétate de cyprotérone par formation de complexes d'inclusion dans les cyclodextrines [Paper presentation]. 5èmes Journées du Club français des Cyclodextrines, Amiens, France. |
Barillaro, V., Van Hees, T., Piel, G., Henry de Hassonville, S., Bertholet, P., Evrard, B., & Delattre, L. (February 2002). Influence de l'ajout d'un composé ternaire dans la formation d'un complexe d'inclusion de miconazole dans les cyclodextrines par CO2 supercritique [Paper presentation]. 5ème Journée du Club français des Cyclodextrines, Amiens, France. |
![]() ![]() | Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Delattre, L., & Evrard, B. (2002). Inclusion Complexes of Cyproterone Acetate with Cyclodextrins in Aqueous Solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44, 289-292. doi:10.1023/A:1023099611604 ![]() |
![]() ![]() | Piel, G., Hayette, M.-P., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., De Mol, P., & Delattre, L. (July 2001). In Vitro Comparison of the Antimycotic Activity of a Miconazole-Hp-Beta-Cyclodextrin Solution with a Miconazole Surfactant Solution. Journal of Antimicrobial Chemotherapy, 48 (1), 83-7. doi:10.1093/jac/48.1.83 ![]() |
![]() ![]() | Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (June 2001). Molecular Modeling Study of Beta- and Gamma-Cyclodextrin Complexes with Miconazole. European Journal of Pharmaceutical Sciences, 13 (3), 271-9. doi:10.1016/S0928-0987(01)00113-0 ![]() |
Piel, G. (March 2001). Les formes galéniques destinées à la sphère ORL: composition et formulation [Paper presentation]. 55ème Journée d'Enseignement Post-Universitaire, Liège, Belgium. |
![]() ![]() | Alvarez, C, Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J.J, & Delattre, L. (2001). Préparation de complexes mebendazole-HPβCD à l'aide de polymères solubles dans l'eau et d'acides organiques. Annales Pharmaceutiques Françaises, 59, 380. ![]() |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Delattre, L., & Evrard, B. (2001). Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids. STP Pharma Sciences, 11 (6), 439-442. ![]() |
Piel, G., Llabres, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (2001). A nuclear magnetic resonance study of the miconazole-b-cyclodextrin inclusion complex in an acidic medium: determination of the structure and stability constants. STP Pharma Sciences, 11 (3), 235-238. ![]() |
![]() ![]() | Ebo, D. G., Piel, G., Conraads, V., & Stevens, W. J. (2001). IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Annals of Allergy, Asthma and Immunology, 87 (3), 243-5. doi:10.1016/S1081-1206(10)62234-X ![]() |
Piel, G., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (December 2000). Etude comparative de l'effet de différents acides et de différentes cyclodextrines sur la solubilité du miconazole, du kétoconazole et de l'itraconazole [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France. |
Van Hees, T., Piel, G., Evrard, B., Henry de Hassonville, S., & Delattre, L. (December 2000). Solubility of p-hydroxybenzoic esters in supercritical carbon dioxide [Poster presentation]. 7th Meeting on Supercritical Fluids, Antibes, France. |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (December 2000). Préparation de complexes mébendazole-HPbCD à l'aide de polymères solubles dans l'eau et d'acides organiques [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France. |
Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (May 2000). Development of a cutaneous hydrogel containing miconazole by the useof hydroxypropyl-b-cyclodextrin and lactic acid [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States. |
Piel, G., Evrard, B., Van Hees, T., Hayette, M.-P., De Mol, P., & Delattre, L. (May 2000). Development of a new parenteral solution of miconazole by the use of cyclodextrins derivatives [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States. |
![]() ![]() | Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (April 2000). Preparation of mebendazole HP-b-cyclodextrin complexes using water soluble polymers and organic acids [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Piel, G. (2000). Etude de l’interaction entre les cyclodextrines et le miconazole: application au développement d’une solution injectable et d’un gel cutané [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/34433 |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (2000). Inclusion of Piroxicam into Beta-Cyclodextrin by Means of Supercritical Carbon Dioxide: Thermal, Spectroscopic and Physicochemical Studies. Journal de Pharmacie de Belgique, 55 (1, Jan-Feb), 30-1. |
![]() ![]() | Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., & Delattre, L. (December 1999). Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-Beta-Cyclodextrin Inclusion Compound. Pharmaceutical Research, 16 (12), 1864-70. doi:10.1023/A:1018955410414 ![]() |
Piel, G. (November 1999). Développement d'un gel cutané à base d'un complexe miconazole-HP-bCD: étude de sa tolérance et de son efficacité [Paper presentation]. 3èmes Journées du Club français des Cyclodextrines, Liège, Belgium. |
Gabelica, V., Piel, G., Baykut, G., Jertz, R., & De Pauw, E. (June 1999). Study of cyclodextrin + drug systems in acidic aqueous soltuion by electrospray ionization F.T. mass spectroscopy [Poster presentation]. 3e MS Pharmaday Massa, Sienna, Italy. |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (May 1999). Inclusion of piroxicam into b-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences. |
![]() ![]() | Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium. |
![]() ![]() | Piel, G., Evrard, B., Van Hees, T., & Delattre, L. (25 March 1999). Comparison of the Iv Pharmacokinetics in Sheep of Miconazole-Cyclodextrin Solutions and a Micellar Solution. International Journal of Pharmaceutics, 180 (1), 41-5. doi:10.1016/S0378-5173(98)00403-7 ![]() |
Piel, G., Evrard, B., Van Hees, T., Llabres, G., & Delattre, L. (1999). Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharma Sciences, 3, 257-260. ![]() |
Evrard, B., De Tullio, P., Chiap, P., Van Hees, T., Piel, G., Crommen, J., Losson, B., & Delattre, L. (1999). The effect of hydroxypropyl-b-cyclodextrins on the pharamacokinetics of albendazole in sheep. In Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials. ![]() |
Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (1999). A Comparative Study of the Antimycotic Activity of a Miconazole Hp-Beta Cyclodextrin Solution and a Surfactant Solution. Journal de Pharmacie de Belgique, 54 (3, May-Jun), 87-8. |
Evrard, B., Chiap, P., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Influence of cyclodextrins on the solubility and the pharmacokinetics of albendazole [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
![]() ![]() | Piel, G., Evrard, B., Fillet, M., Llabres, G., & Delattre, L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. International Journal of Pharmaceutics, 169, 15-22. doi:10.1016/S0378-5173(98)00103-3 ![]() |
Piel, G., Evrard, B., Van Hees, T., Fernandez del Pozo, C., & Delattre, L. (1998). Development of a sustained release dosage form diclofenac-cyclodextrin inclusion complex [Poster presentation]. IX th International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Evrard, B., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Development and pharmacokinetic evaluation of an oral liquid formulation of albendazole with cyclodextrins [Poster presentation]. 2th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Piel, G., Van Hees, T., Evrard, B., & Delattre, L. (1998). A comparative pharmacokinetic study of intravenous solutions containig miconazole with or without cyclodextrins [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (1998). A comparative study of the dissolution properties of piroxicam-b-cyclodextrin inclusion complexes prepared by different methods [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain. |
Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (1998). Preparation of a drug-b-cyclodextrin inclusion compound using supercritical carbon dioxide [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Piel, G., Llabres, G., Fillet, M., Evrard, B., Van Hees, T., & Delattre, L. (1998). A proton nuclear resonance study of the inclusion complex of miconazole with b-cyclodextrin in an acidic medium [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France. |
Evrard, B., Piel, G., Ceccato, A., & Delattre, L. (July 1997). Effects of cyclodextrins on the solubility characteristics of albendazole [Poster presentation]. Pharmaceutical appplication of Cyclodextrins Conference, Lawrence, Kansas, United States. |
Piel, G., Evrard, B., & Delattre, L. (July 1997). Study of the combined effects of cyclodextrins and buffer type on the solubility of miconazole [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States. |
Piel, G., Fillet, M., Evrard, B., Crommen, J., & Delattre, L. (July 1997). Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States. |
![]() ![]() | Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabres, G., Delarge, J., & Delattre, L. (April 1997). Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide-L-Lysine-Cyclodextrin Complexes. Journal of Pharmaceutical Sciences, 86 (4), 475-80. doi:10.1021/js960298k ![]() |
Piel, G., Evrard, B., & Delattre, L. (April 1997). Multicomponent complexes of miconazole with different acids and cyclodextrins [Paper presentation]. VIIth Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
![]() ![]() | Piel, G., Evrard, B., & Delattre, L. (1997). Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. Journal de Pharmacie de Belgique, 52 (3), 124. |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (May 1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties [Paper presentation]. 6ème Forum des Sciences Pharmaceutiques, Blankenberge, Belgium. |
Piel, G., Pochet, L., Delattre, L., & Delarge, J. (April 1996). Study of the influence of g-cyclodextrin on the molsidomine photostability [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary. |
Piel, G., Delneuville, I., & Delattre, L. (April 1996). In vitro and in vivo studies on sodium nimesulide-b-cyclodextrin inclusion complexes [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary. |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (February 1996). Preparation by spray drying of b and g-cyclodextrin inclusion complexes of a poorly soluble non steroidal anti-inflammatory drug [Poster presentation]. Formulation of Poorly-Available Drugs for Oral Administration, European Symposium, Paris, France. |
Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties. Journal de Pharmacie de Belgique, 51, 117. ![]() |
Pirotte, B., Piel, G., Delneuville, I., Neven, P., & Geczy, J. (21 December 1995). WATER-SOLUBLE NIMESULIDE SALT, AND USES THEREOF FOR THE TREATMENT OF INFLAMMATIONS. |
Piel, G., Pochet, L., Delattre, L., & Delarge, J. (June 1995). Photostability studies of molsidomine-cyclodextrin complexes [Poster presentation]. Photostability of drugs, 1st International Meeting, Oslo, Norway. |
Piel, G. (1994). Etude de complexes d'inclusion nimésulide Na-cyclodextrines: fabrication, propriétés physico-chimiques et développement galénique [Specialised master, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/34431 |